Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma

Bibliographic Details
Main Authors: Junya Yan, Long Deng, Jiayi Yu, Xiaowen Wu, Shaoyu Wang, Shundong Cang
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:Clinical and Translational Medicine
Online Access:https://doi.org/10.1002/ctm2.1478
_version_ 1797448565114535936
author Junya Yan
Long Deng
Jiayi Yu
Xiaowen Wu
Shaoyu Wang
Shundong Cang
author_facet Junya Yan
Long Deng
Jiayi Yu
Xiaowen Wu
Shaoyu Wang
Shundong Cang
author_sort Junya Yan
collection DOAJ
first_indexed 2024-03-09T14:12:17Z
format Article
id doaj.art-e4b0a21424cf4e7bafd76a6b75a1b878
institution Directory Open Access Journal
issn 2001-1326
language English
last_indexed 2024-03-09T14:12:17Z
publishDate 2023-11-01
publisher Wiley
record_format Article
series Clinical and Translational Medicine
spelling doaj.art-e4b0a21424cf4e7bafd76a6b75a1b8782023-11-29T06:48:31ZengWileyClinical and Translational Medicine2001-13262023-11-011311n/an/a10.1002/ctm2.1478Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanomaJunya Yan0Long Deng1Jiayi Yu2Xiaowen Wu3Shaoyu Wang4Shundong Cang5Department of OncologyHenan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's HospitalZhengzhou ChinaWestern Medical Branch of the Chinese PLA General Hospital Beijing ChinaDepartment of Radiation Oncology Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Peking University Cancer Hospital & Institute Beijing ChinaDepartment of Renal Cancer and Melanoma Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing) Peking University Cancer Hospital & Institute Beijing ChinaHenan Key Laboratory of Imaging and Intelligent Processing PLA Strategic Support Force Information Engineering University Zhengzhou ChinaDepartment of OncologyHenan Provincial People's Hospital, Zhengzhou University People's Hospital, Henan University People's HospitalZhengzhou Chinahttps://doi.org/10.1002/ctm2.1478
spellingShingle Junya Yan
Long Deng
Jiayi Yu
Xiaowen Wu
Shaoyu Wang
Shundong Cang
Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
Clinical and Translational Medicine
title Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
title_full Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
title_fullStr Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
title_full_unstemmed Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
title_short Multi‐cohort analysis identifies somatic NTRK mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
title_sort multi cohort analysis identifies somatic ntrk mutations as a biomarker for immune checkpoint inhibitor use in cutaneous melanoma
url https://doi.org/10.1002/ctm2.1478
work_keys_str_mv AT junyayan multicohortanalysisidentifiessomaticntrkmutationsasabiomarkerforimmunecheckpointinhibitoruseincutaneousmelanoma
AT longdeng multicohortanalysisidentifiessomaticntrkmutationsasabiomarkerforimmunecheckpointinhibitoruseincutaneousmelanoma
AT jiayiyu multicohortanalysisidentifiessomaticntrkmutationsasabiomarkerforimmunecheckpointinhibitoruseincutaneousmelanoma
AT xiaowenwu multicohortanalysisidentifiessomaticntrkmutationsasabiomarkerforimmunecheckpointinhibitoruseincutaneousmelanoma
AT shaoyuwang multicohortanalysisidentifiessomaticntrkmutationsasabiomarkerforimmunecheckpointinhibitoruseincutaneousmelanoma
AT shundongcang multicohortanalysisidentifiessomaticntrkmutationsasabiomarkerforimmunecheckpointinhibitoruseincutaneousmelanoma